Influence of Sildenafil on Micturition and Urethral Tone in Ovariectomized and Non-ovariectomized Mice

Journal of Sexual Medicine

Volumn 9, Issue 2, 2012, Pages 466-471

  Gamé, Xavier ^a,b   Bouali, Ourdia ^a   Allard, Julien ^b   Gourdy, Pierre ^b   Escourrou, Ghislaine ^a   Tack, Ivan ^b   Rischmann, Pascal ^a   Arnal, Jean François ^b   Malavaud, Bernard ^a  

^a CHU RANGUEIL   (France)

^b INSERM   (France)

Author keywords

Leak point pressure; Micturition; Neuronal nitric oxide synthase; Nitric oxide; Physiology; Sildenafil; Urethra; Urethral tone

Indexed keywords

NITRIC OXIDE SYNTHASE; SILDENAFIL;

ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HORMONE BLOOD LEVEL; MICTURITION; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; SHAM PROCEDURE; URETHRA FUNCTION; URETHRAL TONE;

EID: 84856511449     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02559.x     Document Type: Article

References (22)

1. Mumtaz FH, Khan MA, Thompson CS, Morgan RJ, Mikhailidis DP. Nitric oxide in the lower urinary tract: Physiological and pathological implications. BJU Int 2000;85:567-78.
2. Burnett AL, Calvin DC, Chamness SL, Liu JX, Nelson RJ, Klein SL, Dawson VL, Dawson TM, Snyder SH. Urinary bladder-urethral sphincter dysfunction in mice with targeted disruption of neuronal nitric oxide synthase models idiopathic voiding disorders in humans. Nat Med 1997;3:571-4.
3. Game X, Allard J, Escourrou G, Gourdy P, Tack I, Rischmann P, Arnal JF, Malavaud B. Estradiol increases urethral tone through the local inhibition of neuronal nitric oxide synthase expression. Am J Physiol Regul Integr Comp Physiol 2008;294:R851-7.
4. Kim SO, Lee HS, Ahn K, Park K. Effect of estrogen deprivation on the expression of aquaporins and nitric oxide synthases in rat vagina. J Sex Med 2009;6:1579-86.
5. Werkstrom V, Svensson A, Andersson KE, Hedlund P. Phosphodiesterase 5 in the female pig and human urethra: Morphological and functional aspects. BJU Int 2006;98:414-23.
6. Fibbi B, Morelli A, Vignozzi L, Filippi S, Chavalmane A, De Vita G, Marini M, Gacci M, Vannelli GB, Sandner P, Maggi M. Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. J Sex Med 2010;7:59-69.
7. Francis SH, Turko IV, Corbin JD. Cyclic nucleotide phosphodiesterases: Relating structure and function. Prog Nucleic Acid Res Mol Biol 2000;65:1-52.
8. Andersson KE, Uckert S, Stief C, Hedlund P. Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS. Neurourol Urodyn 2007;26:928-33.
9. Moore PK, Babbedge RC, Wallace P, Gaffen ZA, Hart SL. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol 1993;108:296-7.
10. Bland-Ward PA, Moore PK. 7-Nitro indazole derivatives are potent inhibitors of brain, endothelium and inducible isoforms of nitric oxide synthase. Life Sci 1995;57:PL131-5.
11. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-78.
12. Moore PK, Handy RL. Selective inhibitors of neuronal nitric oxide synthase-Is no NOS really good NOS for the nervous system? Trends Pharmacol Sci 1997;18:204-11.
13. Muntener M, Schurch B, Wefer B, Reitz A. Systemic nitric oxide augmentation leads to a rapid decrease of the bladder outlet resistance in healthy men. Eur Urol 2006;50:112-7, discussion 17-8.
14. Reitz A, Knapp PA, Muntener M, Schurch B. Oral nitric oxide donors: A new pharmacological approach to detrusor-sphincter dyssynergia in spinal cord injured patients? Eur Urol 2004;45:516-20.
15. Kavia RB, Datta SN, Dasgupta R, Elneil S, Fowler CJ. Urinary retention in women: Its causes and management. BJU Int 2006;97:281-7.
16. Fowler CJ, Christmas TJ, Chapple CR, Parkhouse HF, Kirby RS, Jacobs HS. Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: A new syndrome? BMJ 1988;297:1436-8.
17. Datta SN, Kavia RB, Gonzales G, Fowler CJ. Results of double-blind placebo-controlled crossover study of sildenafil citrate (viagra) in women suffering from obstructed voiding or retention associated with the primary disorder of sphincter relaxation (Fowler's syndrome). Eur Urol 2007;51:489-95, discussion 95-7.
18. Mamas MA, Reynard JM, Brading AF. Nitric oxide and the lower urinary tract: Current concepts, future prospects. Urology 2003;61:1079-85.
19. Lin G, Xin ZC, Lue TF, Lin CS. Phosphodiesterase-5 isoforms: Differential cyclic guanyl monophosphate binding and cyclic guanyl monophosphate catalytic activities, and inhibitory effects of sildenafil and vardenafil. J Urol 2006;176:1242-7.
20. Lin CS. Tissue expression, distribution, and regulation of PDE5. Int J Impot Res 2004;16(1 suppl):S8-10.
21. Colleselli K, Stenzl A, Eder R, Strasser H, Poisel S, Bartsch G. The female urethral sphincter: A morphological and topographical study. J Urol 1998;160:49-54.
22. Rud T, Andersson KE, Asmussen M, Hunting A, Ulmsten U. Factors maintaining the intraurethral pressure in women. Invest Urol 1980;17:343-7.